Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations
Cortiula, F., De Ruysscher, D., Steens, M., Wijsman, R., van der Wekken, A., Alberti, M. & Hendriks, L. E. L., May-2023, In: European Journal of Cancer. 184, p. 172-178 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)5 Downloads (Pure) -
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer
ter Heine, R., van den Heuvel, M. M., Piet, B., Deenen, M. J., van der Wekken, A. J., Hendriks, L. E. L., Croes, S., van Geel, R. M. J. M., Jansman, F. G. A., Boshuizen, R. C., Franssen, E. J. F., Smit, A. A. J., Dumoulin, D. W., Oude Munnink, T. H., Smit, E. F., Derijks, H. J., van der Leest, C. H., Hendrikx, J. J. M. A., Moes, D. J. A. R. & de Rouw, N., May-2023, In: Targeted oncology. 18, 3, p. 441-450 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Downloads (Pure) -
External validation of NTCP-models for radiation pneumonitis in lung cancer patients treated with chemoradiotherapy
Niezink, A. G. H., van der Schaaf, A., Wijsman, R., Chouvalova, O., van der Wekken, A. J., Rutgers, S. R., Pieterman, R. M., van Putten, J. W. G., de Hosson, S. M., van der Leest, A. H. D., Ubbels, J. F., Woltman-van Iersel, M., Widder, J., Langendijk, J. A. & Muijs, C. T., Sept-2023, In: Radiotherapy and Oncology. 186, 8 p., 109735.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Downloads (Pure) -
Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer
Veerman, G. D. M., Boosman, R. J., Jebbink, M., Oomen-de Hoop, E., van der Wekken, A. J., Bahce, I., Hendriks, L. E. L., Croes, S., Steendam, C. M. J., de Jonge, E., Koolen, S. L. W., Steeghs, N., van Schaik, R. H. N., Smit, E. F., Dingemans, A. M. C., Huitema, A. D. R. & Mathijssen, R. H. J., May-2023, In: EClinicalMedicine. 59, 11 p., 101955.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Downloads (Pure) -
Optimalisatie van de zorgketen moleculaire diagnostiek bij niet-kleincellig longcarcinoom in Noord-Nederland
Translated title of the contribution :Optimization of the chain-of-care of molecular diagnostics in non-small cell lung cancer in the Northen region of the Netherlands. Research output: Contribution to journal › Article › Academic › peer-review
Activities
-
ALK treatment and resistance in NSCLC
Anthonie Wekken, van der (Speaker)
4-Feb-2020Activity: Talk and presentation › Academic presentation › Academic
-
ALK treatment and resistance in NSCLC
Anthonie Wekken, van der (Speaker)
5-Feb-2020Activity: Talk and presentation › Academic presentation › Academic
-
Supervising PhD student Pim van de Donk
Liesbeth de Vries (Supervisor), Sjoukje Oosting (Co-supervisor) & Anthonie van der Wekken (Co-supervisor)
1-Jan-2020 → …Activity: Examination, teaching and supervision › Supervision and examination of PhD students of the UG › Academic
-
Treatment of mutations with TKI
Anthonie Wekken, van der (Speaker)
2-May-2019Activity: Talk and presentation › Professional or public presentation › Professional
-
European Advisory Board
Anthonie Wekken, van der (Consultant)
17-Dec-2019Activity: External assignment › Consultancy › Professional
Press/Media
-
-
Doelgerichte therapie bij longkanker
Ed Schuuring & Anthonie van der Wekken
01/02/2022
1 Media contribution
Press/Media: Expert Comment › Popular
-
Actionabiliteit van on-target ALK-resistentiemutaties in niet-kleincellig longcarcinoom
04/07/2021
1 item of Media coverage
Press/Media: Expert Comment › Professional
-
Longkanker: welke vorm heb ik?
Wim Timens, Ed Schuuring & Anthonie van der Wekken
01/06/2021
1 Media contribution
Press/Media: Expert Comment › Popular
-